Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease

Clinical trial NCT06606808 · RECRUITING

Trial details

NCT number: NCT06606808
Sponsor: University Medical Center Groningen
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis (UC)Crohn Disease (CD)

Start date: 2024-11-08
Primary completion: 2025-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.